Close

PTC Therapeutics (PTCT) Says EC Ratifies Positive CHMP Opinion for Renewal of Translarna MAA in nmDMD

January 9, 2017 5:49 PM EST Send to a Friend
PTC Therapeutics, Inc. (NASDAQ: PTCT) announced that it received notification today from the European Commission (EC) of its adoption of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login